TDP-43 as a potential retinal biomarker for neurodegenerative diseases

TDP-43 proteinopathies are a spectrum of neurodegenerative diseases (NDDs) characterized by the pathological cytoplasmic aggregation of the TDP-43 protein. These include amyotrophic lateral sclerosis (ALS), frontotemporal lobar degeneration (FTLD), Alzheimer’s disease (AD), chronic traumatic encepha...

Full description

Bibliographic Details
Published in:	Frontiers in Neuroscience
Main Authors:	Margit Glashutter, Printha Wijesinghe, Joanne A. Matsubara
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-02-01
Subjects:	TDP-43 proteinopathy neurodegenerative disease biomarker retina eye brain
Online Access:	https://www.frontiersin.org/articles/10.3389/fnins.2025.1533045/full

Similar Items

Incidence and morphology of secondary TDP-43 proteinopathies: Part 2
by: Albert Acewicz, et al.
Published: (2023-07-01)

Incidence and morphology of secondary TDP-43 proteinopathies: Part 1
by: Albert Acewicz, et al.
Published: (2022-11-01)

Aberrant TDP‐43 phosphorylation: a key wind gap from TDP‐43 to TDP‐43 proteinopathy
by: Zi‐Qi Huang, et al.
Published: (2021-06-01)

RNA-binding deficient TDP-43 drives cognitive decline in a mouse model of TDP-43 proteinopathy
by: Julie C Necarsulmer, et al.
Published: (2023-10-01)

In vivo diagnosis of TDP-43 proteinopathies: in search of biomarkers of clinical use
by: Juan I. López-Carbonero, et al.
Published: (2024-06-01)

TDP-43-M323K causes abnormal brain development and progressive cognitive and motor deficits associated with mislocalised and increased levels of TDP-43
by: Juan M. Godoy-Corchuelo, et al.
Published: (2024-04-01)

Prion-like Spreading of Disease in TDP-43 Proteinopathies
by: Emma Pongrácová, et al.
Published: (2024-11-01)

Observation on pathological TDP ⁃ 43 in amygdala of patients with common neurodegenerative diseases
by: WANG Yuan⁃yuan, et al.
Published: (2022-09-01)

Mitochondrion-Dependent Cell Death in TDP-43 Proteinopathies
by: Chantal B. Lucini, et al.
Published: (2021-04-01)

Lycorine protects motor neurons against TDP-43 proteinopathy-induced degeneration in cross-species models with amyotrophic lateral sclerosis
by: Jing Wen, et al.
Published: (2024-12-01)

Optogenetic induction of TDP-43 aggregation impairs neuronal integrity and behavior in Caenorhabditis elegans
by: Kyung Hwan Park, et al.
Published: (2025-04-01)

Rapid and inducible mislocalization of endogenous TDP43 in a novel human model of amyotrophic lateral sclerosis
by: Johanna Ganssauge, et al.
Published: (2025-07-01)

Peripheral proteinopathy in neurodegenerative diseases
by: Bin Xu, et al.
Published: (2025-01-01)

CK1δ/ε kinases regulate TDP-43 phosphorylation and are therapeutic targets for ALS-related TDP-43 hyperphosphorylation
by: Vivian I. Ko, et al.
Published: (2024-06-01)

Facial Onset Sensory and Motor Neuronopathy: Further Evidence for a TDP-43 Proteinopathy
by: Besa Ziso, et al.
Published: (2015-04-01)

Editorial: Retinal biomarkers of neurodegenerative diseases
by: Sieun Lee, et al.
Published: (2024-10-01)

Functional implication of ubiquitinating and deubiquitinating mechanisms in TDP-43 proteinopathies
by: Non-Nuoc Tran, et al.
Published: (2022-09-01)

Development of a Sensitive and Reliable Meso Scale Discovery-Based Electrochemiluminescence Immunoassay to Quantify TDP-43 in Human Biofluids
by: Jiyan An, et al.
Published: (2024-11-01)

TDP-43-proteinopathy at the crossroads of tauopathy: on copathology and current and prospective biomarkers
by: Abdul R. Nasir, et al.
Published: (2025-10-01)

TDP43 pathology in chronic traumatic encephalopathy retinas
by: Ragini Phansalkar, et al.
Published: (2023-09-01)

The Role of TAR DNA Binding Protein 43 (TDP-43) as a CandiDate Biomarker of Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis
by: Caterina Maria Gambino, et al.
Published: (2023-01-01)

Autophagy and Its Impact on Neurodegenerative Diseases: New Roles for TDP-43 and C9orf72
by: Mauricio Budini, et al.
Published: (2017-05-01)

Secondary Protein Aggregates in Neurodegenerative Diseases: Almost the Rule Rather than the Exception
by: Fabio Moda, et al.
Published: (2023-10-01)

TDP-43 Proteinopathy Specific Biomarker Development
by: Isabell Cordts, et al.
Published: (2023-02-01)

Neuronal models of TDP-43 proteinopathy display reduced axonal translation, increased oxidative stress, and defective exocytosis
by: Alessandra Pisciottani, et al.
Published: (2023-11-01)

Repetitive Mild but Not Single Moderate Brain Trauma Is Associated with TAR DNA-Binding Protein 43 Mislocalization and Glial Activation in the Mouse Spinal Cord
by: Tamara Janković, et al.
Published: (2025-01-01)

Advancements in TDP-43 research: Towards biomarkers and therapeutic targets for amyotrophic lateral sclerosis
by: Yuhan Wu, et al.
Published: (2025-03-01)

Optineurin knock-out forms TDP-43 aggregates to regulate TDP-43 protein levels despite autophagic up-regulation and aberrant TDP-43 expression
by: Yuta Maetani, et al.
Published: (2025-07-01)

Degradation of neurodegenerative disease-associated TDP-43 aggregates and oligomers via a proteolysis-targeting chimera
by: Yu-Ling Tseng, et al.
Published: (2023-04-01)

Decoding TDP-43: the molecular chameleon of neurodegenerative diseases
by: Jixiang Zeng, et al.
Published: (2024-12-01)

TDP-43 Cytoplasmic Translocation in the Skin Fibroblasts of ALS Patients
by: Miguel A. Rubio, et al.
Published: (2022-01-01)

The Role of TDP-43 in SARS-CoV-2-Related Neurodegenerative Changes
by: Dong-Hwi Kim, et al.
Published: (2025-05-01)

Isolation and characterization of antibody fragments selective for human FTD brain derived TDP-43 variants
by: Lalitha Venkataraman, et al.
Published: (2020-09-01)

TDP-43 as a potential biomarker for amyotrophic lateral sclerosis: a systematic review and meta-analysis
by: Vivek Majumder, et al.
Published: (2018-06-01)

Validation of a newly developed immunoassay for TDP-43 in human plasma
by: Sayo Matsuura, et al.
Published: (2024-01-01)

Optogenetic TDP-43 nucleation induces persistent insoluble species and progressive motor dysfunction in vivo
by: Charlton G. Otte, et al.
Published: (2020-12-01)

Cryptic Splicing of GAP43 mRNA is a Novel Hallmark of TDP‐43‐Associated ALS and AD
by: Mingming Yang, et al.
Published: (2025-09-01)

TDP-43 Proteinopathies: A New Player in Neurodegenerative Diseases with Defective Protein Folding
by: Suna Lahut, et al.
Published: (2012-03-01)

Znf179 E3 ligase-mediated TDP-43 polyubiquitination is involved in TDP-43- ubiquitinated inclusions (UBI) (+)-related neurodegenerative pathology
by: Yi-Chao Lee, et al.
Published: (2018-11-01)

TDP-43 regulates cancer-associated microRNAs
by: Xiaowei Chen, et al.
Published: (2017-09-01)